-
Signature
-
/s/ Kathleen Scott, Attorney-in-Fact
-
Stock symbol
-
SPRY
-
Transactions as of
-
Jul 1, 2025
-
Transactions value $
-
-$232,361
-
Form type
-
4
-
Date filed
-
7/3/2025, 04:21 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Karas Eric |
Chief Commercial Officer |
C/O ARS PHARMACEUTICALS, INC., 11682 EL CAMINO REAL, SUITE 120, SAN DIEGO |
/s/ Kathleen Scott, Attorney-in-Fact |
2025-07-03 |
0001951287 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SPRY |
Common Stock |
Options Exercise |
$22.5K |
+15K |
+145.42% |
$1.50 |
25.3K |
Jul 1, 2025 |
Direct |
F1 |
| transaction |
SPRY |
Common Stock |
Sale |
-$255K |
-15K |
-59.25% |
$16.99 |
10.3K |
Jul 1, 2025 |
Direct |
F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SPRY |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-15K |
-2.68% |
$0.00 |
545K |
Jul 1, 2025 |
Common Stock |
15K |
$1.50 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: